001030855 001__ 1030855
001030855 005__ 20250203133204.0
001030855 0247_ $$2doi$$a10.1007/s00406-024-01863-3
001030855 0247_ $$2ISSN$$a0003-9373
001030855 0247_ $$2ISSN$$a0175-758X
001030855 0247_ $$2ISSN$$a0940-1334
001030855 0247_ $$2ISSN$$a1433-8491
001030855 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-05464
001030855 0247_ $$2pmid$$a39048833
001030855 0247_ $$2WOS$$aWOS:001275409200001
001030855 037__ $$aFZJ-2024-05464
001030855 082__ $$a610
001030855 1001_ $$00000-0002-1920-0198$$aSchild, Ann-Katrin$$b0$$eCorresponding author
001030855 245__ $$aSix-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome
001030855 260__ $$aHeidelberg$$bSpringer$$c2024
001030855 3367_ $$2DRIVER$$aarticle
001030855 3367_ $$2DataCite$$aOutput Types/Journal article
001030855 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1738067814_32536
001030855 3367_ $$2BibTeX$$aARTICLE
001030855 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001030855 3367_ $$00$$2EndNote$$aJournal Article
001030855 500__ $$aThe research leading to these results received funding from the German Research Foundation under Grant No (PR 1274/8-1; FR 4479/1-1; WA4101/2-1) supporting CF (FR 4479/1-1) and CW (WA 410/2-1).Open Access funding enabled and organized by Projekt DEAL.
001030855 520__ $$aSome people infected with SARS-CoV-2 report persisting symptoms following acute infection. If these persist for over three months, they are classified as post-COVID-19 syndrome (PCS). Although PCS is frequently reported, detailed longitudinal neuropsychological characterization remains scarce. We aimed to describe the trajectory of cognitive and neuropsychiatric PCS symptoms. 42 individuals with persisting cognitive deficits after asymptomatic to mild/moderate acute COVID-19 at study inclusion received neuropsychological assessment at baseline (BL) and follow-up (FU; six months after BL). Assessments included comprehensive testing of five neurocognitive domains, two cognitive screening tests, and questionnaires on depression, anxiety, sleep, fatigue, and health-related quality of life. Results showed high rates of subjective cognitive complaints at BL and FU (95.2% versus 88.1%) without significant change over time. However, objectively measured neurocognitive disorder (NCD) decreased (61.9% versus 42.9%). All cognitive domains were affected, yet most deficits were found in learning and memory, followed by executive functions, complex attention, language, and perceptual motor functions. In individuals with NCD, the first three domains mentioned improved significantly over time, while the last two domains remained unchanged. Cognitive screening tests did not prove valuable in detecting impairment. Neuropsychiatric symptoms remained constant except for quality of life, which improved. This study emphasizes the importance of comprehensive neuropsychological assessment in longitudinal research and provides valuable insights into the trajectory of long-term neuropsychological impairments in PCS. While cognitive performance significantly improved in many domains, neuropsychiatric symptoms remained unchanged.Keywords: Cognitive deficits; Long COVID; Neurocognitive disorder; Neuropsychology; SARS-CoV-2; Subjective complaints.
001030855 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001030855 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001030855 7001_ $$00000-0003-2781-3143$$aScharfenberg, Daniel$$b1
001030855 7001_ $$00000-0003-1244-244X$$aRegorius, Anton$$b2
001030855 7001_ $$aKlein, Kim$$b3
001030855 7001_ $$00000-0002-1980-8347$$aKirchner, Lukas$$b4
001030855 7001_ $$00000-0003-3330-8231$$aYasemin, Goereci$$b5
001030855 7001_ $$aLülling, Joachim$$b6
001030855 7001_ $$00000-0002-4348-0724$$aMeiberth, Dix$$b7
001030855 7001_ $$00000-0003-0707-0485$$aSchweitzer, Finja$$b8
001030855 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b9$$ufzj
001030855 7001_ $$00000-0003-1067-2102$$aJessen, Frank$$b10
001030855 7001_ $$00000-0002-5609-2472$$aFranke, Christiana$$b11
001030855 7001_ $$0P:(DE-Juel1)131736$$aOnur, Oezguer A.$$b12
001030855 7001_ $$00000-0003-0477-2289$$aJost, Stefanie Theresa$$b13
001030855 7001_ $$00000-0002-3510-9255$$aWarnke, Clemens$$b14
001030855 7001_ $$00000-0002-9335-9594$$aMaier, Franziska$$b15
001030855 773__ $$0PERI:(DE-600)2793981-9$$a10.1007/s00406-024-01863-3$$gVol. 274, no. 8, p. 1945 - 1957$$n8$$p1945 - 1957$$tArchiv für Psychiatrie und Nervenkrankheiten$$v274$$x1433-8491$$y2024
001030855 8564_ $$uhttps://juser.fz-juelich.de/record/1030855/files/PDF.pdf$$yOpenAccess
001030855 8564_ $$uhttps://juser.fz-juelich.de/record/1030855/files/PDF.gif?subformat=icon$$xicon$$yOpenAccess
001030855 8564_ $$uhttps://juser.fz-juelich.de/record/1030855/files/PDF.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001030855 8564_ $$uhttps://juser.fz-juelich.de/record/1030855/files/PDF.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001030855 8564_ $$uhttps://juser.fz-juelich.de/record/1030855/files/PDF.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001030855 909CO $$ooai:juser.fz-juelich.de:1030855$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001030855 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b9$$kFZJ
001030855 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131736$$aForschungszentrum Jülich$$b12$$kFZJ
001030855 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001030855 9141_ $$y2024
001030855 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
001030855 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
001030855 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001030855 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
001030855 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
001030855 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001030855 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
001030855 920__ $$lyes
001030855 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001030855 980__ $$ajournal
001030855 980__ $$aVDB
001030855 980__ $$aUNRESTRICTED
001030855 980__ $$aI:(DE-Juel1)INM-3-20090406
001030855 9801_ $$aFullTexts